Form 8-K - Current report:
SEC Accession No. 0000950170-23-031202
Filing Date
2023-07-03
Accepted
2023-06-30 18:00:17
Documents
12
Period of Report
2023-06-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20230626.htm   iXBRL 8-K 50576
  Complete submission text file 0000950170-23-031202.txt   163936

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnkd-20230626_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnkd-20230626_pre.xml EX-101.PRE 9461
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnkd-20230626.xsd EX-101.SCH 2481
6 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20230626_htm.xml XML 4516
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 231063027
SIC: 2834 Pharmaceutical Preparations